Journal of Neuropathology & Experimental Neurology · 2015 · 74 citations · 23 references
MedicineMolecular GeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaBrain TumorsCancer Molecular DiagnosticsCancer Molecular PathologyGene Fusions In CancerMolecular Classification Of TumorsOncogenic Fusion GenesAstrocytoma PathologyBraf V600e MutationFusion Gene DetectionFusion Rate AssessmentGene Fusion AnalysisHistone Variant H3.3Oncogenic Fusion ProteinsTumor-specific Fusion Genes
Pilocytic astrocytomas (PAs) are increasingly tested for KIAA1549-BRAF fusions. We used reverse transcription polymerase chain reaction for the 3 most common KIAA1549-BRAF fusions, together with BRAF V600E and histone H3.3 K27M analyses to identify relationships of these molecular characteristics with clinical features in a cohort of 32 PA patients. In this group, the overall BRAF fusion detection rate was 24 (75%). Ten (42%) of the 24 had the 16-9 fusion, 8 (33%) had only the 15-9 fusion, and 1 (4%) of the patients had only the 16-11 fusion. In the PAs with only the 15-9 fusion, 1 PA was in the cerebellum and 7 were centered in the midline outside of the cerebellum, that is, in the hypothalamus (n = 4), optic pathways (n = 2), and brainstem (n = 1). Tumors within the cerebellum were negatively associated with fusion 15-9. Seven (22%) of the 32 patients had tumor-related deaths and 25 of the patients (78%) were alive between 2 and 14 years after initial biopsy. Age, sex, tumor location, 16-9 fusion, and 15-9 fusion were not associated with overall survival. Thus, in this small cohort, 15-9 KIAA1549-BRAF fusion was associated with midline PAs located outside of the cerebellum; these tumors, which are generally difficult to resect, are prone to recurrence.
23
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle, Janeta Popovici-Müller, Nicolaos Palaskas et al. · Science · 2013 · 1.2K citations
Medicine, Cancer Biology, Oncology +17
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
Bo Tang, Chandanamali Punchihewa, Ibrahim Qaddoumi et al. · Nature Genetics · 2013 · 841 citations
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas
Margaret Dougherty, Mariarita Santi, Marcia S. Brose et al. · Neuro-Oncology · 2010 · 323 citations · Full text